Veru Inc.

This study aims to see if adding a new oral medication called enobosarm to the injectable weight loss drug semaglutide helps people lose more weight than semaglutide alone. It will enroll 200 adults aged 65 and older with obesity. The main goal is to measure total body weight cha…